BIOFILCHEM / NSE / Biotechnology & Drugs
Biofil Chemicals & Pharmaceuticals Ltd
1Y Price Trend
Key Information
Recommendations
Target High56.36
Target Low25.6
Target Mean0
Target Median0
Risk Metrics
Overall RiskExtreme risk
Board Risk71.31
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Biofil Chemicals & Pharmaceuticals Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals Markets Mojo
Biofil Chemicals FY26 net profit rises to ₹278.60 crore scanx.trade
Biofil Chemicals Q4 FY26: Exceptional Income Masks Operational Weakness Markets Mojo
Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Improved Technicals and Valuation Markets Mojo
Biofil Chemicals & Pharmaceuticals standalone net profit rises 5.00% in the March 2026 quarter Business Standard
Biofil Chemicals FY26 Profit Jumps 399% To ₹2.79 Cr On Asset Sale Whalesbook
Biofil Chemicals & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness Markets Mojo
Modison Ltd leads gainers in 'B' group Dailyhunt
© SharekeyX | Rusaka Technologies 2024-2026

